“…therapy may appear to be of little general importance. However, if the number of individuals affected by XLA (0.5 to 1 per million [4,29,41,65]) and CVID (about 0.5 to 1 per 100,000 [4,29,41,65]) is taken into account, it is safe to state that the incidence of severe viral manifestations, such as encephalitis, was considerably higher in these patients than in the general population, even when enterovirus infections are excluded. For instance, in the years of i.m.…”